Stonepine Capital Management, LLC - AEGERION PHARMACEUTICALS INC ownership

AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 19 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$6,032,000
-54.6%
9,000,000
-45.8%
3.47%
-53.6%
Q1 2017$13,280,000
-23.0%
16,600,000
-31.4%
7.48%
-27.1%
Q4 2016$17,243,000
+8.1%
24,200,0000.0%10.27%
-21.1%
Q3 2016$15,957,000
+61.8%
24,200,000
+39.9%
13.01%
+28.7%
Q2 2016$9,861,00017,300,00010.11%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 9,000,000$6,728,0002.88%
Context Capital Management, LLC 1,250,000$941,0001.71%
Tekla Capital Management LLC 13,000,000$36,801,0001.32%
WOLVERINE ASSET MANAGEMENT LLC 32,934,000$24,701,0000.58%
ZAZOVE ASSOCIATES LLC 16,360,000$12,321,0000.57%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 42,500,000$31,769,0000.49%
FALCON POINT CAPITAL, LLC 1,500,000$1,121,0000.40%
Amici Capital, LLC 10,000,000$7,525,0000.36%
Castle Creek Arbitrage, LLC 4,000,000$3,037,0000.24%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 15,000,000$11,556,000,0000.24%
View complete list of AEGERION PHARMACEUTICALS INC shareholders